| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis, Chronic | 25 | 2019 | 168 | 6.550 |
Why?
|
| Pancreatectomy | 28 | 2021 | 129 | 5.800 |
Why?
|
| Islets of Langerhans Transplantation | 16 | 2021 | 101 | 4.270 |
Why?
|
| Pancreaticojejunostomy | 15 | 2021 | 21 | 2.900 |
Why?
|
| Pancreatic Neoplasms | 15 | 2016 | 332 | 2.400 |
Why?
|
| Pancreatitis | 22 | 2017 | 279 | 2.180 |
Why?
|
| Pancreaticoduodenectomy | 10 | 2021 | 34 | 1.770 |
Why?
|
| Cholecystectomy, Laparoscopic | 8 | 2013 | 59 | 1.330 |
Why?
|
| Pancreas | 11 | 2021 | 225 | 1.300 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 18 | 2019 | 348 | 1.300 |
Why?
|
| Postoperative Complications | 18 | 2017 | 1615 | 1.260 |
Why?
|
| Pancreatic Fistula | 7 | 2021 | 23 | 1.180 |
Why?
|
| Pancreatic Pseudocyst | 9 | 2010 | 24 | 1.130 |
Why?
|
| Islets of Langerhans | 7 | 2021 | 87 | 1.130 |
Why?
|
| Pancreatic Diseases | 4 | 2016 | 66 | 0.930 |
Why?
|
| Treatment Outcome | 28 | 2019 | 7029 | 0.920 |
Why?
|
| Patient Selection | 3 | 2017 | 592 | 0.920 |
Why?
|
| Retrospective Studies | 40 | 2021 | 7277 | 0.890 |
Why?
|
| Surgeons | 2 | 2021 | 68 | 0.870 |
Why?
|
| Intraoperative Complications | 5 | 2012 | 129 | 0.860 |
Why?
|
| Humans | 107 | 2021 | 68618 | 0.840 |
Why?
|
| Adult | 61 | 2021 | 21403 | 0.830 |
Why?
|
| Middle Aged | 54 | 2019 | 21147 | 0.830 |
Why?
|
| Drainage | 10 | 2017 | 133 | 0.820 |
Why?
|
| Transplantation, Autologous | 9 | 2021 | 145 | 0.810 |
Why?
|
| Pancreatic Ducts | 4 | 2012 | 76 | 0.800 |
Why?
|
| Reoperation | 11 | 2013 | 467 | 0.800 |
Why?
|
| Female | 73 | 2021 | 38074 | 0.790 |
Why?
|
| Quality of Life | 8 | 2019 | 1515 | 0.770 |
Why?
|
| Male | 74 | 2021 | 37321 | 0.770 |
Why?
|
| Cystadenoma, Mucinous | 2 | 2010 | 7 | 0.730 |
Why?
|
| Anastomosis, Surgical | 5 | 2015 | 104 | 0.660 |
Why?
|
| Autoimmune Diseases | 3 | 2010 | 186 | 0.650 |
Why?
|
| Traumatology | 1 | 2018 | 20 | 0.630 |
Why?
|
| Adenocarcinoma | 4 | 2010 | 475 | 0.610 |
Why?
|
| Sphincter of Oddi Dysfunction | 2 | 2009 | 48 | 0.610 |
Why?
|
| Length of Stay | 10 | 2019 | 780 | 0.610 |
Why?
|
| Gastric Bypass | 2 | 2009 | 83 | 0.600 |
Why?
|
| Abdominal Injuries | 5 | 2010 | 60 | 0.590 |
Why?
|
| Pain, Intractable | 3 | 2013 | 28 | 0.580 |
Why?
|
| Obesity, Morbid | 2 | 2009 | 172 | 0.550 |
Why?
|
| Aged | 35 | 2019 | 14862 | 0.530 |
Why?
|
| Paraganglioma | 1 | 2015 | 8 | 0.530 |
Why?
|
| Ampulla of Vater | 1 | 2015 | 34 | 0.520 |
Why?
|
| Lymphatic Metastasis | 2 | 2016 | 274 | 0.520 |
Why?
|
| Insulin | 5 | 2019 | 619 | 0.520 |
Why?
|
| Sphincterotomy, Transduodenal | 3 | 2013 | 24 | 0.500 |
Why?
|
| Bile Ducts | 2 | 2012 | 59 | 0.500 |
Why?
|
| Clinical Protocols | 1 | 2016 | 172 | 0.500 |
Why?
|
| Perioperative Care | 1 | 2016 | 100 | 0.500 |
Why?
|
| Neuroendocrine Tumors | 2 | 2016 | 10 | 0.490 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 3259 | 0.490 |
Why?
|
| Elective Surgical Procedures | 3 | 2016 | 95 | 0.480 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 7 | 0.450 |
Why?
|
| Common Bile Duct | 2 | 2011 | 22 | 0.440 |
Why?
|
| Bacterial Infections | 2 | 2013 | 163 | 0.430 |
Why?
|
| Health Services | 1 | 2013 | 87 | 0.420 |
Why?
|
| Psychometrics | 1 | 2015 | 514 | 0.410 |
Why?
|
| Gallbladder Diseases | 1 | 2012 | 16 | 0.400 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 235 | 0.400 |
Why?
|
| Interprofessional Relations | 1 | 2013 | 188 | 0.400 |
Why?
|
| Pain Management | 1 | 2013 | 186 | 0.390 |
Why?
|
| Value of Life | 1 | 2011 | 14 | 0.380 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 106 | 0.370 |
Why?
|
| Adolescent | 18 | 2019 | 8912 | 0.360 |
Why?
|
| Cholestasis | 2 | 2009 | 90 | 0.360 |
Why?
|
| Enteral Nutrition | 2 | 2007 | 157 | 0.350 |
Why?
|
| Risk Management | 1 | 2010 | 37 | 0.350 |
Why?
|
| Laparotomy | 1 | 2010 | 65 | 0.350 |
Why?
|
| Endosonography | 5 | 2010 | 177 | 0.350 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2010 | 22 | 0.350 |
Why?
|
| Analgesics, Opioid | 2 | 2012 | 498 | 0.340 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2010 | 46 | 0.340 |
Why?
|
| Gastrectomy | 1 | 2009 | 24 | 0.340 |
Why?
|
| Peptic Ulcer | 1 | 2009 | 37 | 0.340 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 35 | 0.330 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 131 | 0.320 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2008 | 11 | 0.310 |
Why?
|
| Chronic Disease | 16 | 2008 | 1330 | 0.310 |
Why?
|
| Digestive System Abnormalities | 1 | 2008 | 7 | 0.310 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2008 | 30 | 0.310 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2007 | 48 | 0.300 |
Why?
|
| Splenectomy | 4 | 2010 | 40 | 0.290 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 299 | 0.290 |
Why?
|
| Cholecystectomy | 4 | 2017 | 79 | 0.290 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 63 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2011 | 2324 | 0.280 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 694 | 0.280 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 301 | 0.270 |
Why?
|
| Cholelithiasis | 3 | 1998 | 66 | 0.270 |
Why?
|
| Preoperative Care | 4 | 2010 | 275 | 0.270 |
Why?
|
| Adipose Tissue | 2 | 2017 | 221 | 0.270 |
Why?
|
| Stents | 4 | 2008 | 657 | 0.270 |
Why?
|
| Warfare | 3 | 2010 | 58 | 0.270 |
Why?
|
| Chi-Square Distribution | 4 | 2008 | 546 | 0.260 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2005 | 4 | 0.260 |
Why?
|
| Survival Rate | 6 | 2017 | 1056 | 0.250 |
Why?
|
| Diagnosis, Differential | 5 | 2013 | 1140 | 0.250 |
Why?
|
| South Carolina | 5 | 2018 | 2752 | 0.250 |
Why?
|
| Bilirubin | 2 | 2015 | 51 | 0.240 |
Why?
|
| Catheterization | 4 | 2000 | 209 | 0.240 |
Why?
|
| Lithotripsy | 2 | 2001 | 18 | 0.230 |
Why?
|
| Risk Assessment | 7 | 2011 | 2007 | 0.230 |
Why?
|
| History, 20th Century | 5 | 2018 | 248 | 0.220 |
Why?
|
| Pancreas Transplantation | 2 | 2012 | 71 | 0.220 |
Why?
|
| Intestinal Fistula | 3 | 1994 | 26 | 0.210 |
Why?
|
| Young Adult | 5 | 2016 | 5717 | 0.200 |
Why?
|
| Licensure, Medical | 1 | 2021 | 12 | 0.200 |
Why?
|
| Colonic Diseases | 2 | 1994 | 36 | 0.190 |
Why?
|
| Choledochostomy | 2 | 2011 | 10 | 0.180 |
Why?
|
| General Surgery | 3 | 2021 | 95 | 0.180 |
Why?
|
| Risk Factors | 6 | 2017 | 5731 | 0.180 |
Why?
|
| Wounds, Penetrating | 2 | 2010 | 45 | 0.180 |
Why?
|
| Regression Analysis | 3 | 2007 | 737 | 0.180 |
Why?
|
| Hemorrhage | 2 | 1993 | 328 | 0.170 |
Why?
|
| Educational Measurement | 1 | 2021 | 254 | 0.170 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 58 | 0.170 |
Why?
|
| Blood Glucose | 4 | 2017 | 631 | 0.170 |
Why?
|
| Students, Medical | 1 | 2021 | 210 | 0.160 |
Why?
|
| Cytokines | 3 | 2019 | 866 | 0.160 |
Why?
|
| Mississippi | 1 | 2018 | 11 | 0.160 |
Why?
|
| Ohio | 1 | 2018 | 64 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2011 | 2223 | 0.160 |
Why?
|
| Carcinoma, Papillary | 2 | 2015 | 35 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 2800 | 0.150 |
Why?
|
| Cholangitis | 1 | 2017 | 15 | 0.150 |
Why?
|
| Recurrence | 4 | 2017 | 948 | 0.150 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 35 | 0.150 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 1851 | 0.150 |
Why?
|
| Prognosis | 3 | 2016 | 2093 | 0.140 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2017 | 79 | 0.140 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2017 | 48 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 1 | 2017 | 41 | 0.140 |
Why?
|
| Jejunostomy | 2 | 2000 | 26 | 0.140 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2017 | 61 | 0.140 |
Why?
|
| Graft Survival | 2 | 2017 | 465 | 0.140 |
Why?
|
| Lymph Node Excision | 1 | 2016 | 91 | 0.140 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 59 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2021 | 447 | 0.130 |
Why?
|
| Stem Cells | 1 | 2017 | 248 | 0.130 |
Why?
|
| Allografts | 1 | 2016 | 63 | 0.130 |
Why?
|
| Nutritional Status | 2 | 2007 | 112 | 0.130 |
Why?
|
| Insulin Resistance | 2 | 2015 | 241 | 0.130 |
Why?
|
| Octreotide | 4 | 2007 | 21 | 0.130 |
Why?
|
| Adipokines | 1 | 2015 | 20 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2016 | 258 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 114 | 0.130 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 2008 | 15 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2016 | 117 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2017 | 2358 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2021 | 3705 | 0.120 |
Why?
|
| Laparoscopy | 4 | 2010 | 237 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 2791 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 195 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2015 | 95 | 0.120 |
Why?
|
| Gastrostomy | 1 | 2015 | 110 | 0.120 |
Why?
|
| Reference Values | 2 | 2005 | 579 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2015 | 238 | 0.120 |
Why?
|
| Inflammation | 3 | 2017 | 1030 | 0.120 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 6 | 0.120 |
Why?
|
| Time Factors | 5 | 2019 | 4655 | 0.120 |
Why?
|
| Fat Necrosis | 1 | 1993 | 2 | 0.120 |
Why?
|
| Autografts | 1 | 2013 | 22 | 0.120 |
Why?
|
| Wounds, Stab | 1 | 1993 | 7 | 0.120 |
Why?
|
| Splenic Vein | 2 | 1990 | 4 | 0.110 |
Why?
|
| Diagnosis-Related Groups | 1 | 2013 | 28 | 0.110 |
Why?
|
| Cholesterol | 1 | 2015 | 331 | 0.110 |
Why?
|
| Gallstones | 2 | 2007 | 58 | 0.110 |
Why?
|
| Biliary Tract | 1 | 1993 | 17 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 62 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 99 | 0.110 |
Why?
|
| Apoptosis | 2 | 2017 | 1641 | 0.110 |
Why?
|
| Incidence | 2 | 2009 | 1603 | 0.110 |
Why?
|
| United States | 6 | 2021 | 7367 | 0.110 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 49 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2012 | 58 | 0.110 |
Why?
|
| Nanomedicine | 1 | 2012 | 19 | 0.110 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 34 | 0.110 |
Why?
|
| Leg | 1 | 1993 | 191 | 0.100 |
Why?
|
| Glucose Tolerance Test | 3 | 2019 | 75 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2016 | 506 | 0.100 |
Why?
|
| Angiography | 1 | 1993 | 194 | 0.100 |
Why?
|
| Ureteral Diseases | 1 | 1991 | 5 | 0.100 |
Why?
|
| Urinary Fistula | 1 | 1991 | 7 | 0.100 |
Why?
|
| Urinary Bladder Fistula | 1 | 1991 | 9 | 0.100 |
Why?
|
| Cysts | 2 | 2011 | 70 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 149 | 0.100 |
Why?
|
| Sacrococcygeal Region | 1 | 2011 | 4 | 0.100 |
Why?
|
| Ascites | 2 | 2007 | 38 | 0.100 |
Why?
|
| Blast Injuries | 2 | 2010 | 15 | 0.100 |
Why?
|
| Rectal Diseases | 1 | 2011 | 13 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 281 | 0.100 |
Why?
|
| Hamartoma | 1 | 2011 | 24 | 0.100 |
Why?
|
| Freedom | 1 | 2011 | 9 | 0.100 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2011 | 14 | 0.100 |
Why?
|
| Duodenal Diseases | 2 | 1991 | 15 | 0.100 |
Why?
|
| Colonoscopy | 2 | 1991 | 156 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2013 | 267 | 0.090 |
Why?
|
| Abscess | 1 | 1990 | 37 | 0.090 |
Why?
|
| Splenic Artery | 1 | 1990 | 16 | 0.090 |
Why?
|
| Sclerosis | 1 | 2010 | 32 | 0.090 |
Why?
|
| Vipoma | 1 | 2010 | 2 | 0.090 |
Why?
|
| Gastrinoma | 1 | 2010 | 2 | 0.090 |
Why?
|
| Somatostatinoma | 1 | 2010 | 3 | 0.090 |
Why?
|
| Insulinoma | 1 | 2010 | 4 | 0.090 |
Why?
|
| Glucagonoma | 1 | 2010 | 3 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 1990 | 38 | 0.090 |
Why?
|
| Jejunum | 1 | 2010 | 26 | 0.090 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2010 | 13 | 0.090 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 236 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 1 | 1994 | 364 | 0.090 |
Why?
|
| Surgical Staplers | 1 | 1989 | 4 | 0.090 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2010 | 20 | 0.090 |
Why?
|
| Obesity | 2 | 2015 | 1076 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 369 | 0.090 |
Why?
|
| History, 19th Century | 3 | 2008 | 95 | 0.090 |
Why?
|
| Child | 6 | 2015 | 6405 | 0.090 |
Why?
|
| Rectum | 1 | 1989 | 62 | 0.090 |
Why?
|
| Endoscopy | 2 | 1998 | 464 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 110 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 36 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 349 | 0.080 |
Why?
|
| Mice | 6 | 2017 | 8474 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2011 | 652 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2009 | 75 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 206 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 504 | 0.080 |
Why?
|
| Colon | 1 | 1989 | 168 | 0.080 |
Why?
|
| Vaginal Fistula | 1 | 1988 | 3 | 0.080 |
Why?
|
| Survivors | 1 | 2011 | 256 | 0.080 |
Why?
|
| Colposcopy | 1 | 1988 | 20 | 0.080 |
Why?
|
| Explosions | 1 | 1988 | 4 | 0.080 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2007 | 17 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 951 | 0.080 |
Why?
|
| Nutritional Support | 1 | 2007 | 22 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2009 | 931 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 447 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 51 | 0.070 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 334 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 1864 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1174 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2017 | 147 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2007 | 74 | 0.070 |
Why?
|
| Safety | 2 | 2006 | 145 | 0.070 |
Why?
|
| Animals | 8 | 2017 | 20881 | 0.070 |
Why?
|
| Duodenum | 1 | 1986 | 47 | 0.070 |
Why?
|
| Cause of Death | 2 | 2006 | 241 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Military Medicine | 2 | 1988 | 53 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 38 | 0.070 |
Why?
|
| Diverticulum | 1 | 1986 | 29 | 0.070 |
Why?
|
| Abdominal Abscess | 1 | 2006 | 8 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 1994 | 839 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2016 | 2689 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 1986 | 58 | 0.070 |
Why?
|
| Pancreatic Function Tests | 1 | 2005 | 6 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2006 | 82 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2007 | 174 | 0.070 |
Why?
|
| Morbidity | 1 | 2005 | 130 | 0.060 |
Why?
|
| Cell Death | 2 | 2017 | 329 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2005 | 274 | 0.060 |
Why?
|
| Age Distribution | 1 | 2005 | 320 | 0.060 |
Why?
|
| Mice, Obese | 2 | 2015 | 33 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 245 | 0.060 |
Why?
|
| Digestive System | 1 | 2004 | 35 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 626 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 277 | 0.060 |
Why?
|
| Leptin | 2 | 2015 | 80 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 120 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2006 | 276 | 0.060 |
Why?
|
| Critical Care | 1 | 2006 | 263 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2004 | 161 | 0.060 |
Why?
|
| Austria | 1 | 2003 | 17 | 0.060 |
Why?
|
| Health Status | 1 | 2006 | 429 | 0.060 |
Why?
|
| Macrophages | 2 | 2017 | 647 | 0.050 |
Why?
|
| Wounds, Gunshot | 1 | 1983 | 48 | 0.050 |
Why?
|
| Body Weight | 2 | 2015 | 554 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2000 | 216 | 0.050 |
Why?
|
| Liver | 3 | 2015 | 1118 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 1046 | 0.050 |
Why?
|
| Job Application | 1 | 2021 | 3 | 0.050 |
Why?
|
| Governing Board | 1 | 2021 | 12 | 0.050 |
Why?
|
| Lithiasis | 1 | 2001 | 2 | 0.050 |
Why?
|
| Intraoperative Period | 1 | 2001 | 62 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1553 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2001 | 69 | 0.050 |
Why?
|
| Cholangiography | 3 | 1998 | 55 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2019 | 18 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 36 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 51 | 0.040 |
Why?
|
| Geography | 1 | 2019 | 80 | 0.040 |
Why?
|
| Hemostatics | 1 | 1999 | 47 | 0.040 |
Why?
|
| Acetylglucosamine | 1 | 1999 | 46 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 193 | 0.040 |
Why?
|
| Cholecystitis | 1 | 1998 | 12 | 0.040 |
Why?
|
| Triage | 2 | 1990 | 109 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2017 | 22 | 0.040 |
Why?
|
| Ceruletide | 1 | 2017 | 8 | 0.040 |
Why?
|
| Acinar Cells | 1 | 2017 | 8 | 0.040 |
Why?
|
| Amylases | 1 | 2017 | 17 | 0.040 |
Why?
|
| Multiple Chronic Conditions | 1 | 2017 | 9 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2017 | 31 | 0.040 |
Why?
|
| Polysaccharides | 1 | 1999 | 176 | 0.040 |
Why?
|
| Choledocholithiasis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 78 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 42 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 58 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2017 | 49 | 0.040 |
Why?
|
| Propensity Score | 1 | 2017 | 117 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 138 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2017 | 191 | 0.040 |
Why?
|
| Antithrombin III | 1 | 2017 | 23 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2019 | 195 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2017 | 1342 | 0.040 |
Why?
|
| Thromboplastin | 1 | 2017 | 21 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 200 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2017 | 238 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 110 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 82 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 122 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2017 | 87 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 140 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 111 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 242 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 132 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2016 | 12 | 0.030 |
Why?
|
| SEER Program | 1 | 2016 | 153 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 1753 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 42 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2016 | 39 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 244 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 330 | 0.030 |
Why?
|
| Palliative Care | 1 | 1998 | 271 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 74 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 92 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2021 | 596 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Adiponectin | 1 | 2015 | 52 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 498 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 71 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 81 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1420 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 770 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 432 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 532 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 630 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1174 | 0.030 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 191 | 0.030 |
Why?
|
| Acute Disease | 2 | 1994 | 658 | 0.030 |
Why?
|
| Equipment Failure | 2 | 1993 | 112 | 0.030 |
Why?
|
| Biliary Fistula | 1 | 1994 | 3 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 186 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 800 | 0.030 |
Why?
|
| Colostomy | 1 | 1994 | 15 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Cutaneous Fistula | 1 | 1994 | 11 | 0.030 |
Why?
|
| Pheochromocytoma | 1 | 1993 | 22 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1993 | 26 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 40 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1200 | 0.030 |
Why?
|
| Debridement | 1 | 1993 | 55 | 0.030 |
Why?
|
| Lipids | 1 | 2015 | 298 | 0.030 |
Why?
|
| Colectomy | 1 | 1994 | 64 | 0.030 |
Why?
|
| Cystic Duct | 1 | 1993 | 5 | 0.030 |
Why?
|
| Bile Duct Diseases | 1 | 1993 | 28 | 0.030 |
Why?
|
| Viscera | 1 | 1993 | 16 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1034 | 0.030 |
Why?
|
| Necrosis | 1 | 1994 | 239 | 0.030 |
Why?
|
| Vascular Diseases | 2 | 1990 | 94 | 0.030 |
Why?
|
| Surgery Department, Hospital | 1 | 1993 | 19 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 148 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2012 | 120 | 0.030 |
Why?
|
| Alcoholism | 1 | 2001 | 1109 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 236 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1993 | 169 | 0.030 |
Why?
|
| Punctures | 1 | 1992 | 35 | 0.030 |
Why?
|
| Arteries | 1 | 1993 | 108 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1992 | 95 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 1992 | 49 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2550 | 0.020 |
Why?
|
| Intestine, Small | 2 | 2004 | 89 | 0.020 |
Why?
|
| Disaster Planning | 1 | 1993 | 105 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1991 | 108 | 0.020 |
Why?
|
| Contraindications | 1 | 1990 | 52 | 0.020 |
Why?
|
| Ethanol | 1 | 2017 | 893 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 2011 | 75 | 0.020 |
Why?
|
| Gastroscopy | 1 | 1991 | 45 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1991 | 120 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 1993 | 150 | 0.020 |
Why?
|
| New Zealand | 1 | 1990 | 28 | 0.020 |
Why?
|
| Spain | 1 | 1990 | 34 | 0.020 |
Why?
|
| Disasters | 1 | 1993 | 204 | 0.020 |
Why?
|
| Anemia, Pernicious | 1 | 1990 | 11 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 396 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1990 | 20 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1990 | 66 | 0.020 |
Why?
|
| Multiple Trauma | 1 | 2010 | 50 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1293 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2010 | 204 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 124 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 617 | 0.020 |
Why?
|
| Calcinosis | 1 | 1991 | 241 | 0.020 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1989 | 20 | 0.020 |
Why?
|
| Portal Vein | 1 | 1989 | 46 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 540 | 0.020 |
Why?
|
| Cuba | 1 | 1988 | 8 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 453 | 0.020 |
Why?
|
| Amputation, Traumatic | 1 | 1988 | 11 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2008 | 127 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 4848 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 33 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 1986 | 40 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2007 | 157 | 0.020 |
Why?
|
| Forecasting | 1 | 2007 | 277 | 0.020 |
Why?
|
| Fibrosis | 1 | 2007 | 371 | 0.020 |
Why?
|
| Military Personnel | 1 | 1988 | 221 | 0.020 |
Why?
|
| Liver Extracts | 1 | 2004 | 1 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2004 | 36 | 0.020 |
Why?
|
| Gallbladder | 1 | 2004 | 15 | 0.020 |
Why?
|
| Sucrose | 1 | 2004 | 58 | 0.020 |
Why?
|
| Iohexol | 1 | 2004 | 82 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 601 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 586 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 318 | 0.010 |
Why?
|
| History, 16th Century | 1 | 1983 | 8 | 0.010 |
Why?
|
| Europe | 1 | 1983 | 196 | 0.010 |
Why?
|
| Hemostatic Techniques | 1 | 1999 | 23 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1999 | 111 | 0.010 |
Why?
|
| Acetylation | 1 | 1999 | 94 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1999 | 69 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 301 | 0.010 |
Why?
|
| Infant | 2 | 1998 | 2891 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 1180 | 0.010 |
Why?
|
| Swine | 1 | 1999 | 672 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1998 | 3187 | 0.010 |
Why?
|
| Sphincter of Oddi | 1 | 1998 | 51 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 1998 | 85 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1999 | 185 | 0.010 |
Why?
|
| Manometry | 1 | 1998 | 276 | 0.010 |
Why?
|
| Dilatation | 1 | 1995 | 58 | 0.010 |
Why?
|
| Maintenance and Engineering, Hospital | 1 | 1993 | 3 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1993 | 14 | 0.010 |
Why?
|
| Electric Power Supplies | 1 | 1993 | 26 | 0.010 |
Why?
|
| Diploidy | 1 | 1992 | 7 | 0.010 |
Why?
|
| Trauma Centers | 1 | 1993 | 197 | 0.010 |
Why?
|
| Duodenal Obstruction | 1 | 1991 | 2 | 0.010 |
Why?
|
| Pyloric Stenosis | 1 | 1991 | 5 | 0.010 |
Why?
|
| Gastroenterostomy | 1 | 1991 | 8 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1992 | 489 | 0.010 |
Why?
|
| Somatostatin | 1 | 1989 | 36 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1990 | 64 | 0.010 |
Why?
|
| Mesenteric Veins | 1 | 1989 | 10 | 0.010 |
Why?
|
| Radiography | 1 | 1989 | 572 | 0.000 |
Why?
|